Ingunn Hatlevoll

881 total citations · 1 hit paper
10 papers, 500 citations indexed

About

Ingunn Hatlevoll is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ingunn Hatlevoll has authored 10 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Ingunn Hatlevoll's work include Esophageal Cancer Research and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Esophageal and GI Pathology (3 papers). Ingunn Hatlevoll is often cited by papers focused on Esophageal Cancer Research and Treatment (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Esophageal and GI Pathology (3 papers). Ingunn Hatlevoll collaborates with scholars based in Norway and Sweden. Ingunn Hatlevoll's co-authors include Magnus Nilsson, Gjermund Johnsen, Lars Lundell, Gabriella Alexandersson von Döbeln, Nils Glenjen, Fredrik Klevebro, Signe Friesland, Jon A. Tsai, P Lind and Anne-Birgitte Jacobsen and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Ingunn Hatlevoll

8 papers receiving 493 citations

Hit Papers

A randomized clinical trial of neoadjuvant chemotherapy v... 2016 2026 2019 2022 2016 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
    2016 273 citations Fredrik Klevebro, Gabriella Alexandersson von Döbeln et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingunn Hatlevoll Norway 6 386 386 73 65 62 10 500
Benjamin R. Alsop United States 7 295 0.8× 374 1.0× 76 1.0× 36 0.6× 66 1.1× 15 458
Nicolas Briez France 9 626 1.6× 671 1.7× 116 1.6× 45 0.7× 75 1.2× 10 799
Naoki Shinno Japan 13 278 0.7× 286 0.7× 111 1.5× 33 0.5× 40 0.6× 49 434
Jean‐Michel Balon France 6 275 0.7× 307 0.8× 62 0.8× 30 0.5× 54 0.9× 8 398
Takaaki Hanyu Japan 11 244 0.6× 241 0.6× 60 0.8× 17 0.3× 42 0.7× 46 372
J.W. van Sandick Netherlands 9 424 1.1× 391 1.0× 92 1.3× 17 0.3× 42 0.7× 14 543
Peng-Zhi Ni China 10 175 0.5× 160 0.4× 66 0.9× 34 0.5× 50 0.8× 13 295
King‐Han Shen Taiwan 6 278 0.7× 184 0.5× 53 0.7× 31 0.5× 37 0.6× 8 360
Tadayoshi Hashimoto Japan 10 170 0.4× 161 0.4× 95 1.3× 38 0.6× 28 0.5× 39 277
Kota Momose Japan 8 156 0.4× 153 0.4× 70 1.0× 45 0.7× 17 0.3× 46 249

Countries citing papers authored by Ingunn Hatlevoll

Since Specialization
Citations

This map shows the geographic impact of Ingunn Hatlevoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingunn Hatlevoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingunn Hatlevoll more than expected).

Fields of papers citing papers by Ingunn Hatlevoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingunn Hatlevoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingunn Hatlevoll. The network helps show where Ingunn Hatlevoll may publish in the future.

Co-authorship network of co-authors of Ingunn Hatlevoll

This figure shows the co-authorship network connecting the top 25 collaborators of Ingunn Hatlevoll. A scholar is included among the top collaborators of Ingunn Hatlevoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingunn Hatlevoll. Ingunn Hatlevoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mjelle, Robin, Ola Magne Vagnildhaug, Trude R. Balstad, et al.. (2025). Serum miRNA Signatures in Cancer Cachexia Depend on Systemic Inflammation. Current Oncology. 32(11). 620–620.
2.
Hatlevoll, Ingunn, John‐Arne Skolbekken, Line Oldervoll, Arne Wibe, & Eva Hofsli. (2021). Colorectal cancer patients’ experiences with supervised exercise during adjuvant chemotherapy—A qualitative study. Scandinavian Journal of Medicine and Science in Sports. 31(12). 2300–2309. 7 indexed citations
3.
Hatlevoll, Ingunn, Line Oldervoll, Arne Wibe, et al.. (2020). Physical exercise during adjuvant chemotherapy for colorectal cancer—a non-randomized feasibility study. Supportive Care in Cancer. 29(6). 2993–3008. 7 indexed citations
4.
Döbeln, Gabriella Alexandersson von, Fredrik Klevebro, Niels Hilmer Nielsen, et al.. (2018). Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial. Diseases of the Esophagus. 32(2). 115 indexed citations
5.
Klevebro, Fredrik, Anne-Birgitte Jacobsen, Niels Hilmer Nielsen, et al.. (2018). PS02.120: NEOADJUVANT CHEMOTHERAPY VERSUS NEOADJUVANT CHEMORADIOTHERAPY FOR CANCER OF THE OESOPHAGUS OR GASTRO-OESOPHAGEAL JUNCTION: LONG-TERM RESULTS. Diseases of the Esophagus. 31(Supplement_1). 155–155. 1 indexed citations
6.
Klevebro, Fredrik, Gabriella Alexandersson von Döbeln, N. Wang, et al.. (2016). A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Annals of Oncology. 27(4). 660–667. 273 indexed citations breakdown →
7.
Döbeln, Gabriella Alexandersson von, Magnus Nilsson, Gunnar Adell, et al.. (2015). Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer. Practical Radiation Oncology. 6(3). e53–e59. 21 indexed citations
8.
Hofsli, Eva, Wenche Sjursen, Wenche S. Prestvik, et al.. (2013). Identification of serum microRNA profiles in colon cancer. British Journal of Cancer. 108(8). 1712–1719. 75 indexed citations
9.
Glenjen, Nils, Ingunn Hatlevoll, Geir Egil Eide, et al.. (2012). FLOX regimen (5-FU, folinic acid, oxaliplatin) and FLIRI regimen (5-FU, folinic acid, irinotecan) as first-line treatment in metastatic and locally advanced gastric cancer: A randomized phase II study.. Journal of Clinical Oncology. 30(4_suppl). 71–71. 1 indexed citations
10.
Friesland, Signe, Gun Wickart-Johansson, Charlotte Bratthäll, et al.. (2012). A phase I/II study (TaxXel) on the treatment with docetaxel in combination with capecitabin in patients with metastatic esophageal cancer or cancer in the cardia region.. Journal of Clinical Oncology. 30(15_suppl). e14531–e14531.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin R. Alsop Breakdown of academic impact, for papers by Nicolas Briez Breakdown of academic impact, for papers by Naoki Shinno Breakdown of academic impact, for papers by Jean‐Michel Balon Breakdown of academic impact, for papers by Takaaki Hanyu Breakdown of academic impact, for papers by J.W. van Sandick Breakdown of academic impact, for papers by Peng-Zhi Ni Breakdown of academic impact, for papers by King‐Han Shen Breakdown of academic impact, for papers by Tadayoshi Hashimoto Breakdown of academic impact, for papers by Kota Momose
Rankless by CCL
2026